3Nemenoff RA,Winitz S,Qian N-X.Phosphoulation and activation of a high molecular weight form of PLA2 by P42microtubule-associated protein kinase C. J Biol Chem, 1993, 268: 1960-1964.
4King GL, Shiba T, Oliver J, et al. Cellular and molecular abnormalities in the vascular endothelium of diabetes mellitus. Annu Rev Med, 1994,45: 179-182.
5Rodriguez-Manas L, Angulo J, Vallejo S, et al. Early and intermediate Amadori glycosylation adducts, oxidative stress, and endothelial dysfunction in the streptozotocin-induced diabetic rats vasculature. Diabetologia, 2003, 46: 556-566.
6Osicka TM, Yu Y, Lee V, Panagiotopoulos S, Kemp BE, Jerums G. Aminoguanidine and ramipril prevent diabetes-induced increases in protein kinase C activity in glomeruli, retina and mesenteric artery.Clin Sci, 2001,100: 249-57.
6Takada J,Machado MA,Peres SB,et al.Neonatal streptozotocin-induced diabetes mellitus:a model of insulin resistance associated with loss of adipose mass[J].Metabolism,2007,56(7):977-984.
7Su J,Li SJ,Chen ZH,et al.Evaluation of podocyte lesion in patients with diabetic nephropathy:Wilms' tumor-1 protein used as a podocyte marker[J].Diabetes Res Clin Pract,2010,87(2):167-175.
8Su J,Zhang P,Zhang JJ,et al.Effects of total glucosides of paeony on oxidative stress in the kidney from diabetic rats[J].Phytomedicine,2010,17(3-4):254-260.
9Austin RC.The unfolded protein response in health and disease[J].Antioxid Redox Signal,2009,11(9):2279-2287.
10Drel VR,Xu W,Zhang J,et al.Poly(adenosine 5' diphosphate-ribose) polymerase inhibition counteracts multiple manifestations of experimental type 1 diabetic nephropathy[J].Endocrinology,2009,150(12):5273-5283.
